Amplifying innovation in healthcare
Through investment and project management, we amplify the value of pre-commercial projects with high value potential to a stage where they can commercialize.
Bridging the translational gap
Life science translation faces a persistent gap between basic research or drug discovery and clinical proof-of-concept. The scarcity of private investment in early-stage medical device and diagnostic development drives the need for inventors to leverage alternative funding sources to advance innovation. Amplify will provide the resources to develop promising therapeutics, medical devices, and diagnostics, focusing on discoveries from the Mass General Brigham hospitals, including Massachusetts General Hospital and Brigham and Women’s Hospital.
We will develop a translational plan alongside the PI, and then will operate the project on their behalf.
Dione T. Kobayashi, PhD, Operating Partner
Amplify seeks to work closely with MGB Investigators to develop their innovative therapeutic projects into commercializable assets. Just as innovation takes many forms, Amplify projects will span diseases and therapeutic modalities. Investigators with projects that aspire to create therapies for patients who require new and better medicines are encouraged to contact Dr. Kobayashi.
Devices & Diagnostics
Erin McKenna, MBA, Operating Partner
Amplify is interested in working with MGB investigators to develop and advance medical device and diagnostic technologies with the ability to have significant impact on improving patient care. Amplify projects can serve a variety of unmet clinical needs and utilize a broad range of technology types. Investigators with projects with transformative potential are encouraged to contact Erin McKenna.
Dione Kobayashi, PhD
Ronald Cobb, PhD
Robert Hubbard, PhD
Kendall Square Location
One Main Street, Suite 510
Cambridge, MA 02142